Pliva, Farmaceutska Industrija, Dionicko Drustvo

Pliva D.d.

Marijan Tudja

Aleksandar Danilovski

Darko Filic

Miljenko Dumic

Miljenko Dumi&cacute;

Darko Fili&cacute;

Bozena Klepi&cacute;

Miljenko Dumić

Bozena Klepić

Darko Filić

The invention relates to a novel polymorph V of torasemide, to a process for its preparation, to its use as a raw material for the preparation of crystalline modifications I and III of torasemide, to amorphous torasemide modifications and to pharmaceutically acceptable salts of torasemide, to pharmaceutical forms containing the said novel polymorph V of torasemide as the active ingredient as well as to its use.

Polymorph V of torasemide

The invention relates to compositions of N-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsul fonamide and cyclic oligosaccharides with increased release, to methods for their preparation, to pharmaceutical froms containing them as well as to their use.

Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides

The present invention relates to an amorphous torasemide modification, to a process for preparation thereof, to its use as a raw material for the preparation of pharmaceutically acceptable salts of torasemide, to pharmaceutical forms containing the amorphous torasemide modification as well as to its use as a diuretic.

Amorphous torasemide modification

Growing community of inventors

Zagreb, Croatia

Marijan Tudja